Vancouver COVID-19 therapy developer AbCellera eyeing potential IPO as early as fall

ad+1

Biotechnology startup set to decide in the next two weeks whether to start a process to go public, CEO Carl Hansen says


from Report on Business - The Globe and Mail
Read The Rest:theglobeandmail...

0 comments: